Embecta Share Holder Equity 2021-2024 | EMBC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Embecta share holder equity from 2021 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Embecta share holder equity from 2021 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$151.7B
Elevance Health (ELV)	$90.6B
Cencora (COR)	$47.6B
Natera (NTRA)	$23.1B
DiDi Global (DIDIY)	$22.8B
ICON (ICLR)	$16.2B
Avantor (AVTR)	$14.8B
Revvity (RVTY)	$14.5B
BioMerieux (BMXMF)	$14.3B
Viatris (VTRS)	$13B
Solventum (SOLV)	$12.9B
CochLear (CHEOY)	$12.8B
Medpace Holdings (MEDP)	$11.2B
Doximity (DOCS)	$10.9B
EUROFINS SCIENT (ERFSF)	$10B
HealthEquity (HQY)	$9.7B
Sonic Healthcare (SKHHY)	$8.5B
Charles River Laboratories (CRL)	$8.5B
Amplifon S.p.A (AMFPF)	$6.1B
Bausch + Lomb (BLCO)	$5.7B
BrightSpring Health Services (BTSG)	$3.9B
Sotera Health (SHC)	$3.9B
Organon (OGN)	$3.8B
Surgery Partners (SGRY)	$3.3B
Concentras Parent (CON)	$3B
Alignment Healthcare (ALHC)	$2.9B
PACS (PACS)	$2.2B
Ardent Health Partners (ARDT)	$2.1B
Teladoc Health (TDOC)	$2.1B
Progyny (PGNY)	$1.9B